Clinical Trial Details
| Trial ID: | L3472 |
| Source ID: | NCT01046422 |
| Associated Drug: | Bms-770767 |
| Title: | Safety Study of BMS-770767 in Subjects With Type 2 Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Type 2 |
| Interventions: | DRUG: BMS-770767|DRUG: BMS-770767|DRUG: BMS-770767|DRUG: BMS-770767|DRUG: Placebo|DRUG: Metformin |
| Outcome Measures: | Primary: Fasting Plasma Glucose Improvement, Within seven days following dosing | Secondary: Mean daily glucose (3-day 7 pt-fingerstick), Within 28 days following dosing|Four (4)-hour post-prandial glucose AUC, Within 28 days following dosing|HbA1C, Within 28 days following dosing|Lipid profiles, Within 28 days following dosing |
| Sponsor/Collaborators: | Sponsor: Bristol-Myers Squibb |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 76 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT |
| Start Date: | 2010-05 |
| Completion Date: | 2011-01 |
| Results First Posted: | |
| Last Update Posted: | 2015-10-12 |
| Locations: | Marina Raikhel, Md, Lomita, California, 90717, United States|Nevada Alliance Against Diabetes, Las Vegas, Nevada, 89101, United States|Local Institution, Caboolture, Queensland, 4510, Australia|Local Institution, Meadowbrook, Queensland, 4131, Australia|Local Institution, Daw Park, South Australia, 5041, Australia|Local Institution, Geelong, Victoria, 3220, Australia|Local Institution, Nedlands, Western Australia, 6009, Australia|Local Institution, Winnipeg, Manitoba, R3P 1R9, Canada|Local Institution, Mount Pearl, Newfoundland and Labrador, A1N 1W7, Canada|Local Institution, Brampton, Ontario, L6T 3J1, Canada|Local Institution, Toronto, Ontario, M4G 3E8, Canada|Local Institution, Charlottetown, Prince Edward Island, C1A 5Y9, Canada|Local Institution, Drummondville, Quebec, J2B 7T1, Canada|Local Institution, Lachine, Quebec, H8S 2E4, Canada|Local Institution, Laval, Quebec, H7T 2P5, Canada|Local Institution, Montreal, Quebec, H3J 2V5, Canada|Local Institution, Incheon, 405-760, Korea, Republic of|Local Institution, Suwon, 443-721, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT01046422 |
